General News

General News | Mar. 24, 2016

2016 Lupus Insight Prize Call for Nominations Underway

Lupus Organizations Continue Collaborating to Spark Innovation and Scientific Advances in Lupus Research

General News | Feb. 23, 2016

Lupus Foundation of America Accepting Applications to Expedite Progress in Lupus Research

Through a rigorous peer-review process, the Foundation will fund the most promising research focused on improving the quality of life for people with lupus.

General News | Jan. 13, 2016

National Institutes of Health Releases Plan to Expedite Lupus Treatments and Cures

The research plan identifies and examines opportunities to increase scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies

General News | Nov. 09, 2015

Two Prominent Investigators Recognized For Their Achievements In Lupus Research

10th Anniversary of the Evelyn V. Hess Award Celebrates Past Honorees

General News | Nov. 07, 2015

Research Findings Provide Evidence of Progress and Hope For Improved Quality of Life

Eight LFA-supported research studies presented during the American College of Rheumatology Annual Scientific Meeting

General News | Jul. 28, 2015

Statement on the Results of Epratuzumab Study for the Treatment of Lupus

Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO

General News | Jul. 15, 2015

Lupus Foundation of America’s Collaboration in PARTNERS Seeks to Improve Pediatric Research and Care

Learn more about PARTNERS (Patients, Advocates and Rheumatology Teams Network for Research and Service), a new initiative.

General News | Jun. 17, 2015

Lupus Foundation of America Hosts Capitol Conversation on 21st Century Cures Moderated by Chuck Todd

National Advocacy Awards Dinner recognizes leaders from Congress, federal agencies, industry and the research community.